Visitors and news

The Screening Group organized this meeting for all principal investigators, programme managers, and key collaborators from the study sites involved in this project, to discuss Data and Safety Monitoring Board (DSMB) recommendations, study progress, and recent findings.

Dr Basu, Dr Muwonge and Dr Sankaranaranan participated as international faculty in several sessions and interactive discussions focussing on cervical cancer elimination. Many of our field collaborators participated in sessions about cervical cancer screening (Dr Bhatla, Dr Esmy, Dr Joshi), HPV related oropharyngeal cancers (Dr Ramdas), Experiences on cervical cancer screening implementation and challenges (Dr Ashrafunnessa), HPV vaccination implementation challenges (Dr Verma), Advanced screening technologies (Dr Anantharaman).

This article describes the process and outcomes of the resource-stratified screening and treatment of preinvasive lesions of cervix guidelines suitable for low middle and income countries: A single visit approach is encouraged and treatment may be offered based on colposcopy diagnosis ('see and treat') or even on the basis of HPV test or VIA results ('screen and treat'), if compliance cannot be ensured. The Federation of Obsterician and Gynaecologists of India Good Clinical Practice Recommendations (FOGSI) GCPR are appropriately designed for countries with varied resource situations to ensure an acceptable cervical cancer prevention strategy. Read the article.

Dr Partha Basu explained in this editorial published today in The Guardian the role of Artificial Intelligence (AI) in the future of cancer early diagnosis and detection within the framework of 2019 Innovations in Oncology Campaign. Cancer detection in women may be more efficient and affordable with the use of artificial intelligence. However, more research is needed to address its real-world applicability and safety. Read the article.

Cancer is the fourth leading cause of death in the Eastern Mediterranean Region with an estimated 676 500 new cases and 419 000 cancer deaths in 2018. The most common cancers in the region are respectively breast, colorectal, lung, liver and bladder. Authors of this editorial concluded that breast, colorectal and cervical cancer can be more effectively managed and prioritized through adoption of the suitable national early detection strategy when feasible.
Read the article

A new study led by researchers from the IARC and partners, published today in The Lancet Global Health, provides a comprehensive assessment of the global incidence and mortality patterns of cervical cancer.
Read the article and the IARC Press Release

Dr. Partha Basu attended this technical meeting within the framework of the iPAAC project organized by the Cancer Society of Finland to discuss the roadmap and deliverables to take a look into new developments and screening criteria and the new openings of cancer screening in Europe.

Get ready for the Giving Tuesday 2019 and support research on cancer prevention. Donate to increase the impact of International Agency for Research on Cancer global projects! Find out more about CanScreen5 project which improves the quality of cancer screening practices worldwide.
Read more about how to support IARC and learn more about opportunities of giving Tuesday 2019

Dr Zhihua Liu from the Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China visited the Screening group to discuss areas of potential collaboration.

As part of the CANelles project, Dr Patricia Villain from the Screening Group team organized this workshop to guide the development and implementation of shared decision making (SDM) online tools to help women make decisions in breast cancer screening. The participants include Dr Robert Smith (American Cancer Society, USA), Dr Raúl Murillo (Centro Javeriano de Oncología, Colombia), Dr Sonali Johnson (Union for International Cancer Control), and Dr Eleni Tolma (Kuwait University Health Sciences Center).